News & events

News & events

Filter by:
  • Management TeamNews

BioStock interview with CEO John Glasspool on VMX-C001 at BioCapital Europe

  • Management TeamNews

VarmX announces appointment of John Glasspool as CEO

Leadership team fully strengthened to drive next phase of development Leiden, The Netherlands, 12 november 2024 VarmX, a biotech company...

  • News

VarmX raises seed capital for development of VMX-C001

VarmX, a Dutch, Leiden based biotech company focusing on the development of therapies in the field of hemostasis and thrombosis,...

VMX-C001: Transforming the treatment of bleeding in patients taking Factor Xa DOACs

Portfolio